Martínez José-Antonio, Nicolás Josep-María, Marco Francesc, Horcajada Juan-Pablo, Garcia-Segarra Gloria, Trilla Antoni, Codina Carles, Torres Antoni, Mensa Josep
Department of Infectious Diseases, Hospital Clínic, IDIBAPS -University of Barcelona, Spain.
Crit Care Med. 2006 Feb;34(2):329-36. doi: 10.1097/01.ccm.0000195010.63855.45.
To compare a mixing vs. a cycling strategy of use of anti-Pseudomonas antibiotics on the acquisition of resistant Gram-negative bacilli in the critical care setting.
Prospective, open, comparative study of two strategies of antibiotic use.
Two medical intensive care units of a university hospital.
A total of 346 patients admitted for >or=48 hrs to two separate medical intensive care units during an 8-month period.
Patients, who according to the attending physician's judgment required an anti-Pseudomonas regimen, were assigned to receive cefepime/ceftazidime, ciprofloxacin, a carbapemen, or piperacillin-tazobactam in this order. "Cycling" was accomplished by prescribing one of these antibiotics during 1 month each. "Mixing" was accomplished by using the same order of antibiotic administration on consecutive patients. Interventions were carried out during two successive 4-month periods, starting with mixing in one unit and cycling in the other.
Swabbing of nares, pharynx, and rectum and culture of respiratory secretions were obtained thrice weekly. The main outcome variable was the proportion of patients acquiring enteric or nonfermentative Gram-negative bacilli resistant to the antibiotics under intervention. The scheduled cycling of antibiotics was only partially successful. Although the expected antibiotic was the most prevalent anti-Pseudomonas agent used within the corresponding period, it never accounted for >45% of all anti-Pseudomonas antimicrobials administered. During mixing, a significantly higher proportion of patients acquired a strain of Pseudomonas aeruginosa resistant to cefepime (9% vs. 3%, p = .01), and there was a trend toward a more frequent acquisition of resistance to ceftazidime (p = .06), imipenem (p = .06), and meropenem (p = .07). No differences in the rate of acquisition of potentially resistant Gram-negative bacilli or incidence of intensive care unit-acquired infections and infections due to particular organisms were observed.
In critically ill medical patients, a strategy of monthly rotation of anti-Pseudomonas beta-lactams and ciprofloxacin may perform better than a strategy of mixing in the acquisition of P. aeruginosa resistant to selected beta-lactams.
比较在重症监护环境中,使用抗假单胞菌抗生素时采用混合用药与循环用药策略对革兰氏阴性杆菌耐药性产生的影响。
对抗生素使用的两种策略进行前瞻性、开放性、对照研究。
一所大学医院的两个内科重症监护病房。
在8个月期间,共有346名入住两个独立内科重症监护病房且住院时间≥48小时的患者。
根据主治医师的判断,需要接受抗假单胞菌治疗方案的患者,按此顺序接受头孢吡肟/头孢他啶、环丙沙星、碳青霉烯类或哌拉西林-他唑巴坦治疗。“循环用药”是通过在每个月规定使用其中一种抗生素来实现。“混合用药”是通过对连续的患者按相同的抗生素给药顺序来实现。干预措施在两个连续的4个月期间进行,一个病房从混合用药开始,另一个病房从循环用药开始。
每周三次采集鼻腔、咽部和直肠拭子以及呼吸道分泌物进行培养。主要观察变量是在干预下获得对所用抗生素耐药的肠道或非发酵革兰氏阴性杆菌的患者比例。抗生素的预定循环用药仅部分成功。尽管预期的抗生素是相应时间段内使用最普遍的抗假单胞菌药物,但它在所有使用的抗假单胞菌抗菌药物中所占比例从未超过45%。在混合用药期间,获得对头孢吡肟耐药的铜绿假单胞菌菌株的患者比例显著更高(9%对3%,p = 0.01),并且对头孢他啶(p = 0.06)、亚胺培南(p = 0.06)和美罗培南(p = 0.07)产生耐药性的频率有增加趋势。在获得潜在耐药革兰氏阴性杆菌的发生率、重症监护病房获得性感染率以及特定病原体引起的感染方面未观察到差异。
在重症内科患者中,每月轮换使用抗假单胞菌β-内酰胺类药物和环丙沙星的策略,在获得对选定β-内酰胺类药物耐药的铜绿假单胞菌方面可能比混合用药策略效果更好。